secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2021-09-13T23:59:59+00:00
Accession:  0001104659-21-115113
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast appoints Jonathan B. MacKenzie as Chief Accounting Officer effective Sept 13, 2021
--------------------------------------------------------------------------------

- MacKenzie succeeds James P. Maloney, who remains CFO; Maloney ceases as Interim CAO.
- Annual base salary of $280,000; target annual bonus of 40% of base salary, prorated for 2021.
- Cash sign-on bonus of $20,000; equity sign-on award of $25,000 in time-based deferred shares vesting ratably over 3 years.
- MacKenzie previously a Managing Director at PwC Risk Assurance; no family relationships or arrangements with other officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000110465921115113/0001104659-21-115113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000110465921115113/tm2127498d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-115113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer